Company SynAct Pharma AB

Equities

SYNACT

SE0008241491

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research

Delayed Nasdaq Stockholm Other stock markets 09:42:01 22/05/2024 BST			5-day change	1st Jan Change
6.955 ^SEK	-3.34%		-3.40%	-21.23%

04-23	Synact Pharma AB Announces Changes in Nomination Committee Ahead of the 2024 Annual General Meeting	CI
03-20	Sweden's SynAct Pharma Names New CEO	MT

SynAct Pharma AB is a manufacturer of biological products. The Company is located in Lund, Sweden. It develops medicines for acute impairment in inflammatory diseases. The company's drug candidate AP1189 is intended for the treatment of arthritis including psoriasis arthritis.

Number of employees: 5

Managers	Title	Age	Since
Björn Westberg DFI	Director of Finance/CFO	62	31/05/23
Kirsten Harting CTO	Chief Tech/Sci/R&D Officer	-	02-14
Thomas Boesen COO	Chief Operating Officer	-	25/01/21
Thomas Jonassen CTO	Chief Tech/Sci/R&D Officer	-	-
James Knight PRN	Corporate Officer/Principal	-	10/02/21

Members of the board	Title	Age	Since
Thomas Jonassen CTO	Chief Tech/Sci/R&D Officer	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	35,570,980	24,706,334 ( 69.46 %)	0	69.46 %

Name	Equities	%	Valuation
Investcorp Corporate Investment Group 11.14 %	3,962,790	11.14 %	2 M kr
Heights Capital Management, Inc. 10.54 %	3,750,000	10.54 %	2 M kr
TJ Biotech Invest APS 6.076 %	2,161,225	6.076 %	1 M kr
NORDNET AB 4.776 %	1,698,777	4.776 %	1 M kr
Ryan Quinn 4.217 %	1,500,000	4.217 %	934 770 kr
Quantass Invest APS 3.853 %	1,370,419	3.853 %	854 018 kr
GoodWind Holding GmbH 3.266 %	1,161,777	3.266 %	723 996 kr
Nils Thomas von Koch 3.144 %	1,118,210	3.144 %	696 846 kr
Torbjørn Bjerke 2.363 %	840,532	2.363 %	523 803 kr
Handelsbanken Fonder AB 1.240 %	441,077	1.240 %	274 870 kr

SynAct Pharma AB

Scheelevägen 2

223 81, Lund

+46 1 03 00 10 23

http://www.synactpharma.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
SYNACT PHARMA AB	-21.23%	27.76M
MODERNA, INC.	+44.48%	55.07B
LONZA GROUP AG	+44.02%	40.22B
IQVIA HOLDINGS INC.	-0.86%	41.79B
CELLTRION, INC.	-7.59%	28.17B
ICON PUBLIC LIMITED COMPANY	+12.30%	26.28B
ALNYLAM PHARMACEUTICALS, INC.	-21.83%	18.93B
BIO-TECHNE CORPORATION	+7.15%	13.03B
MEDPACE HOLDINGS, INC.	+29.40%	12.26B
UNITED THERAPEUTICS CORPORATION	+25.15%	12.21B

Other Biotechnology & Medical Research